Answer
Cannabidiol (Epidyolex) is licensed from age 2 years as add-on treatment for seizures associated with Lennox–Gastaut or Dravet syndrome, together with clobazam, and for seizures associated with tuberous sclerosis complex.
Sources for this answer
- Epidyolex 100 mg/ml oral solutionJazz Pharmaceuticals Research UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated
Sources checked